In 2022, the digital diabetes management industry was valued at USD 18.9 billion and will grow at 20% CAGR from 2023 to 2032, attributed to the growing prevalence of diabetes globally.
The market share from the services segment will grow at more than 18.5% CAGR from 2023 to 2032, owing to rapid advancements in diabetes management software and apps.
North America digital diabetes management market size reached over USD 6 billion in 2022, attributed to the favorable government initiatives for diabetes treatment.
Major digital diabetes management industry players include Abbott Laboratories, F.Hoffmann-La Roche Ltd, Senseonics, Tandem Diabetes Care, Inc, Medtronic Plc, Dexcom, Inc, and Insulet Corporation, among others.